TY - GEN
T1 - Enhanced tumor cell separation by surfaces functionalized with combinations of bioadhesive proteins
AU - Myung, Ja Hye
AU - Launiere, Cari A.
AU - Gajjar, Khyati A.
AU - Eddington, David T.
AU - Hong, Seungpyo
PY - 2010
Y1 - 2010
N2 - We have achieved the evenly distributed, stable immobilization of proteins: P-selectin, E-selectin, anti-EpCAM, and mixtures of the proteins, using epoxy-functionalized glass slides. The immobilized proteins maintained their own biological adhesive functions that induce cell rolling and stationary binding. The enhanced separation capacity and capture efficiency by combination of these immobilized proteins hold promise to be potentially utilized for future cell specific capturing devices. We are presently translating these results to a device to capture CTCs from the mixture of other cell lines and whole blood. In addition to the potential use of this device as a metastatic cancer treatment tool by filtering CTCs from the bloodstream, the advantages of this device include the ability to collect CTCs from whole blood under continuous flow without labeling or damaging the CTCs. Therefore, the collected CTCs can be extracted and potentially be subject of further analysis such as genetic understanding and responses for currently available therapeutic drugs by culture expansion.
AB - We have achieved the evenly distributed, stable immobilization of proteins: P-selectin, E-selectin, anti-EpCAM, and mixtures of the proteins, using epoxy-functionalized glass slides. The immobilized proteins maintained their own biological adhesive functions that induce cell rolling and stationary binding. The enhanced separation capacity and capture efficiency by combination of these immobilized proteins hold promise to be potentially utilized for future cell specific capturing devices. We are presently translating these results to a device to capture CTCs from the mixture of other cell lines and whole blood. In addition to the potential use of this device as a metastatic cancer treatment tool by filtering CTCs from the bloodstream, the advantages of this device include the ability to collect CTCs from whole blood under continuous flow without labeling or damaging the CTCs. Therefore, the collected CTCs can be extracted and potentially be subject of further analysis such as genetic understanding and responses for currently available therapeutic drugs by culture expansion.
UR - http://www.scopus.com/inward/record.url?scp=77955073363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955073363&partnerID=8YFLogxK
U2 - 10.1115/nemb2010-13210
DO - 10.1115/nemb2010-13210
M3 - Conference contribution
AN - SCOPUS:77955073363
SN - 9780791843925
T3 - Proceedings of the ASME 1st Global Congress on NanoEngineering for Medicine and Biology 2010, NEMB2010
SP - 125
EP - 126
BT - Proceedings of the ASME 1st Global Congress on NanoEngineering for Medicine and Biology 2010, NEMB2010
PB - ASME
T2 - 1st Global Congress on NanoEngineering for Medicine and Biology: Advancing Health Care through NanoEngineering and Computing, NEMB 2010
Y2 - 7 February 2010 through 10 February 2010
ER -